Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000145291 | SCV000192368 | likely benign | not specified | 2013-04-25 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000145291 | SCV000202209 | benign | not specified | 2013-12-20 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000306424 | SCV000441452 | benign | Seckel syndrome 1 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Laboratory for Molecular Medicine, |
RCV000145291 | SCV000538378 | benign | not specified | 2016-03-28 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000587232 | SCV000697779 | benign | not provided | 2016-04-27 | criteria provided, single submitter | clinical testing | Variant summary: The c.1776T>A variant involves the alteration of a non-conserved nucleotide resulting in a synonymous change. 4/4 in silico tools via Alamut predict the variant to eliminate a cryptic splice donor site, thereby potential resulting in a protective effect on normal splicing. The variant was observed in the large, broad control population, ExAC, with an allele frequency of 55% which includes 19,239 homozygous occurrences. Therefore this synonymous variant is the major allele and has been classified as Benign. |
Invitae | RCV000587232 | SCV001729236 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000587232 | SCV001751843 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000306424 | SCV001775062 | benign | Seckel syndrome 1 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV003315925 | SCV004015534 | benign | Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000145291 | SCV001741429 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000145291 | SCV001963623 | benign | not specified | no assertion criteria provided | clinical testing |